UW Health Comprehensive Program for Bleeding Disorders

Madison, Wisconsin 53792

1 studies enrolling now · 1 studies all time

What they study most

Concomitant VWD and Hemophilia, Von Willebrand Disease, Type 3

Studies at this site

• Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A — Recruiting now